Sentences with phrase «for diagnostics company»

He gave Posin, now 63, information for diagnostics company SleepQuest, about 30 miles from his home in San Francisco.
(Yesterday, the agency launched precisionFDA, a web platform for diagnostics companies, researchers, and healthcare providers to validate genetic tests against reference materials and share their results.)

Not exact matches

Holmes and Theranos made waves in Silicon Valley and the diagnostics industry two years ago, when investors lined up to boost the valuation of a company that claimed it would soon offer more than 1,000 varieties of blood diagnostics tests without the need for a syringe.
It previously focused on making diagnostic machinery for the biotech companies.
Diversified healthcare company Abbott Laboratories on Friday agreed to buy Alere for about $ 4.48 billion, ending a prolonged legal battle over its plan to buy the diagnostic - testing company.
Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 10 - Q.
The company, in turn, would began offering educational workshops and clinics, for a modest fee, where they'd share some of the physiological benefits of custom - fit saddles and offer a diagnostic assessment of a rider's gear.
The company's Gene - RADAR system can be used at the actual hospitals where patients go; it's portable, making it an especially convenient system for Zika virus testing since blood samples don't have to be shipped off to diagnostic labs.
Theranos is a diagnostics company with fast finger - prick blood testing technology that aims to upend the traditional health care establishments by making it easier, less expensive and less uncomfortable to get tested for various conditions.
San Diego's Astute Medical has been purchased for $ 90 million by French diagnostics company BioMeriéux.
Founder Elizabeth Holmes, who is facing a two - year ban by U.S. regulators from running a clinical testing company, used the session at the American Association for Clinical Chemistry's annual scientific meeting to introduce the «miniLab» testing device, a 95 - pound diagnostic tool that can fit on a tabletop.
About ChipCare ChipCare is a Toronto - based company producing life - saving diagnostics for infectious and non-communicable diseases in remote health settings with a mobile, simple - to - use & lab quality blood - testing platform.
Companies that provide drug development and other product development services, equipment, software and services for research, manufacturing discovery and medical diagnostics.
Brian Peifer, broker of record for Royal LePage Peifer Realty in Chatham, Ont., along with office manager Deb Roberts, donated more than $ 4,000 from their company to the Chatham - Kent Health Alliance Diagnostic Imaging Machine Campaign.
The company met many of Buffett's criteria for purchase: strong return on capital, a family run company, $ 135 million in annual revenue and a business plan that's difficult for competitors to copy, said Kenkel, who is international marketing manager for an Omaha health care diagnostics company.
One of the world's leading medical technology companies produces and sells an extensive range of medical supplies, laboratory and diagnostic equipment for health care facilities, life science institutes, and clinical laboratories.
It's a decision which stands to impede access to genes for diagnostic and other purposes, while protecting the right of biomedical companies to extract higher returns for life - saving technology.
Ronald Niemeijer is director global marketing food diagnostics at R - Biopharm AG and responsible for R - Biopharm's marketing strategy in food analysis and the development and implementation of the company's digital marketing and content marketing strategies.
Pete has supported legislation to increase Medicare reimbursements for screening and diagnostic mammographies; fund research centers to study the relationship between the environment and breast cancer; and require insurance companies to guarantee at least 48 hours hospital care after a mastectomy.»
Second, the deal bars insurance companies from charging copayments or coinsurance for either screening mammograms or follow - up diagnostic imaging.
Chicago - based Hill - Rom Holdings Inc. bought 101 - year - old company for $ 2.05 billion in September from the Allyn family and has continued to manufacture medical diagnostic equipment under the Welch Allyn name in Skaneateles.
It's taken 13 years, but an upstate New York company, Logical Images, has finally received a patent for the software that runs its visual diagnostic system.
The company wanted to use it as a diagnostic marker for disease: If synthetic versions of antibodies could be tagged with aequorin in the lab, then whenever they matched up with an antigen (or surface protein) of a specific pathogen in blood or tissue, the sample would glow.
Vaccines developed using proteins rather than live viruses can help protect animals and subsequently humans from insect - borne viruses, according to Alan Young, chief scientific officer for Medgene Labs, an animal health company that develops therapeutics and diagnostics, including vaccines.
This loophole means that companies ranging from small start - ups offering just one or two tests to much larger diagnostic labs that offer thousands of tests can develop and charge for new LDTs much more easily than they can for most other categories of medical products.
This system and our other diagnostics sensors are being supported for commercialisation through a University spin out company, Ohmedics Ltd..»
In 2006, the neurotechnology industry comprised over 500 companies, developing drugs, devices and diagnostics for the brain and nervous system, generating worldwide revenues of $ 120.5 billion.
Any company that has significant diagnostic information and genomic capabilities, if they want to go for the gold ring, they try to figure out how to make it useful to the health industry rather than just producing research tools,» says David Galas, a professor at the Institute for Systems Biology in Seattle, Washington, and the vice president and chief science officer for biological and life sciences at the Battelle Memorial Institute in Columbus, Ohio.
Some of the diagnostics companies, for instance, are expanding, and there's been an influx of big pharma into the area recently.»
The Duke team has previously explored blood tests to examine a patient's RNA for gene signatures to distinguish bacterial and viral infections in the upper respiratory tract and is working with a private company to develop potential diagnostics.
One early project was to help Genoptix — a Novartis daughter - company acquired in 2011 and located in Carlsbad, California — to commercialize a diagnostic test for lung cancer patients.
As you don't need to make cDNA to offer a diagnostic test, campaigners for women's health hope that other companies will now leap in, and bring down the cost of testing for BRCA1 and BRCA2.
For many companies, the Therapeutic Discovery Project Program will actually mean a cash grant to help develop a drug or diagnostic.
A Million dollars is on offer to the researcher or company that develops cheap and simple diagnostic tests for chlamydia and gonorrhoea.
She expects her company's first product, a diagnostic test for waterborne parasites, to reach the market by the end of 2009.
The research scientist just 4 years into her first industry job with a company that makes diagnostic tests and reagents, who finds as she reenters the job market that she is not a strong candidate for bench - science jobs in the biotech industry because she has been labeled a «diagnostics industry» employee.
«From a business standpoint, there is not much of an incentive for drug companies to produce these diagnostics,» says Randy Scott of Genomic Health.
Since it was patented in 1984, more than 1,000 companies have licensed the T7 system to produce proteins for commercial purposes, including medical diagnostics and treatments.
• Customized mutation screening assays Biotage, the manufacturing company of the genetic analyzer PyroMark ID, offers in its database more than 1,000 customized assays for routine clinical screening diagnostics.
Her company will satisfy a need in the marketplace for reasonably priced custom monoclonal antibodies for diagnostic and therapeutic uses, she said.
In order to most rapidly realize the value of genetics for human health, deCODE is currently partnering with life sciences companies to accelerate their target discovery, validation, and prioritization efforts, yielding improved patient stratification for clinical trials and essential companion diagnostics.
About deCODE deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of diagnostics and drugs for common diseases.
With more than 1,200 international actors from 35 + countries, such as big pharma, emerging and small biotech, diagnostics companies, pre-seed / seed / Series A investors, as well as professionals from tech transfer, academia and research institutions, BioFIT is the leading partnering event in Europe for technology transfer, academia - industry collaborations and early - stage innovations in the field of Life Sciences.
Today the company supplies high technology particles and polymer products for in vitro diagnostics and life science research applications.
Curetis N.V. (the «Company» and, together with Curetis USA Inc. and Curetis GmbH, «Curetis»), a developer of next - level molecular diagnostic solutions, today announced the successful completion of clinical performance evaluation and CE - IVD marking of its novel Unyvero Application Cartridge, UTI, for the diagnosis of severe urinary tract infections.
DENVER — A pre-competitive consortia of pharmaceutical, diagnostic companies and academic associations, including the International Association for the Study of Lung Cancer (IASLC), announced phase I results of the «BLUEPRINT PD - L1 IHC ASSAY COMPARISON PROJECT» at the Annual Meeting of the American Association for Cancer Research (AACR) on April 19.
It will strengthen Ireland's ability to attract foreign direct investment from companies active in the multi-trillion euro global market for diagnostics, treatments and medtech for neurological diseases, and facilitate indigenous companies seeking to access this market.
In 1994 he founded Definiens, a company dedicated to developing advanced processing tools for maximizing the information that can be gathered from images, with particular use for applications in medical diagnostics.
The expense and effort are increased by the FDA requirement that any company applying for approval of a drug targeted against a specific gene - driven abnormality must also produce a diagnostic test for that abnormality.
The companies will use the discovery as the basis for further research and development in both diagnostics and therapeutics.
a b c d e f g h i j k l m n o p q r s t u v w x y z